KCT0006121
Not yet recruiting
未知
Hybrid Cardiac Rehabilitation in Heart Failure
ConditionsDiseases of the circulatory system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the circulatory system
- Sponsor
- Samsung Medical Center
- Enrollment
- 82
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •? Male and female patients aged 20\-75 who are admitted to the department of cardiology at Samsung Medical Center due to heart failure (including heart transplant and LVAD) and get referred to cardiac rehabilitation.
- •? Patients who have agreed to participate as study subjects
Exclusion Criteria
- •? Patients who have contraindications to exercise training and cardiopulmonary exercise testing
- •? Patients who are evaluated as unsuitable to participate in this study due to uncompensated conditions, uncontrolled conditions such as severe ventricular arrhythmia, or other medical reasons.
- •? Patients with severe impairment in understanding and performing in this study (ex; cognitive impairment including advanced dementia)
- •? Patients who refused to participate in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Effectiveness of center and home based Cardiac Rehabilitation on Psychological distress, Sense of Coherence and Quality of Life among patients undergoing Coronary Artery Bypass Graft (CABG) surgeryHealth Condition 1: I798- Other disorders of arteries, arterioles and capillaries in diseases classified elsewhereCTRI/2020/12/029596ot applicable for this study
Not yet recruiting
Not Applicable
Effect of hybrid cardiac rehabilitation using a smart deviceDiseases of the circulatory systemKCT0005893Inje University Sanggye Paik Hospital64
Recruiting
Not Applicable
Comprehensive Hybrid Cardiac Rehabilitation Trial on Heart FailureHeart Failure NYHA Class IIHeart Failure NYHA Class IIINCT06313684Universidad de La Frontera152
Completed
Not Applicable
Study of a heart failure treatment using a combination drug consisting of reduced coenzyme Q10, astaxanthin, citrulline, and zincheart failureJPRN-UMIN000020203Tokorozawa Heart Center, Medical Corporation Ouyuukai50
Not yet recruiting
Phase 4
ovel Interventions in Heart Failure with Preserved Ejection Fraction using TadalafilHeart Failure with Preserved Ejection FractionCardiovascular - Other cardiovascular diseasesACTRN12612000684820South Australian Health and Medical Reseasrch Institute20